Prostate specific antigen (PSA) has been the most valuable tool in the detection, staging and monitoring of prostate cancer [2,3]. Although widely accepted as a prostate tumor marker, it is prostate tissue but not prostate cancer specific as PSA levels have been reported to increase in men with benign prostatic hyperplasia (BPH) and prostatitis [4].